Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Khalili Biotech is an Iranian biotechnology company specializing in the development and production of recombinant proteins and vaccines. Founded by Dr. Sediqeh Khalili, a prominent researcher from the Pasteur Institute of Iran, the company focuses on bridging the gap between academic research and industrial production of biologics. Its portfolio includes biosimilar products and diagnostic reagents aimed at addressing public health needs in Iran and the broader Middle East region. The company operates as a knowledge-based entity, emphasizing innovation in bioprocessing, molecular cloning, and cell line development. Khalili Biotech plays a significant role in the local biopharmaceutical ecosystem by providing affordable alternatives to essential medicines and vaccines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sediqeh Khalili.